As of 11:16 AM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 1 |
| Avg. Estimate | -0.01 | 0 | -0.03 | 0.04 |
| Low Estimate | -0.02 | 0 | -0.04 | 0.04 |
| High Estimate | -0.01 | 0 | -0.03 | 0.04 |
| Year Ago EPS | -0.04 | -0.02 | -0.15 | -0.03 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 1 |
| Avg. Estimate | 3.86M | 4.3M | 15.99M | 18.05M |
| Low Estimate | 3.7M | 4.09M | 15.7M | 18.05M |
| High Estimate | 4.02M | 4.52M | 16.28M | 18.05M |
| Year Ago Sales | -- | 3.74M | 14.24M | 15.99M |
| Sales Growth (year/est) | -- | 14.90% | 12.30% | 12.90% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.05 | -0.06 | -0.02 | -0.04 |
| EPS Actual | -0.04 | -0.02 | -0.06 | -0.02 |
| Difference | 0.01 | 0.04 | -0.04 | 0.02 |
| Surprise % | 20.00% | 66.70% | -200.00% | 50.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.01 | 0 | -0.03 | 0.04 |
| 7 Days Ago | -0.01 | 0 | -0.03 | 0.04 |
| 30 Days Ago | -0.01 | 0 | -0.03 | 0.04 |
| 60 Days Ago | -0.01 | 0 | -0.06 | 0.01 |
| 90 Days Ago | -0.01 | 0 | -0.06 | 0.01 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | NEPH | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 75.00% | -- | -- | 7.70% |
| Next Qtr. | 100.00% | -- | -- | 10.30% |
| Current Year | 80.00% | -- | -- | 4.40% |
| Next Year | 233.30% | -- | -- | 12.00% |
| Next 5 Years (per annum) | -- | -- | -- | 11.27% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | Benchmark: Speculative Buy to Speculative Buy | 5/15/2024 |
| Upgrade | Benchmark: Hold to Speculative Buy | 3/8/2024 |
| Initiated | B. Riley Securities: Buy | 1/26/2021 |
| Initiated | Benchmark: Speculative Buy | 10/24/2019 |
| Initiated | Maxim Group: Buy | 10/4/2019 |
Related Tickers
NXGL NEXGEL, Inc.
2.2300
+2.76%
MHUA Meihua International Medical Technologies Co., Ltd.
0.7676
+3.73%
POCI Precision Optics Corporation, Inc.
6.07
-3.27%
DXR Daxor Corporation
8.83
+3.64%
GCTK GlucoTrack, Inc.
2.3501
-2.08%
HBIO Harvard Bioscience, Inc.
2.8750
-0.69%
STXS Stereotaxis, Inc.
1.8450
-0.81%
ZTEK Zentek Ltd.
1.0300
-3.74%
KRMD KORU Medical Systems, Inc.
2.2150
+3.50%
MLSS Milestone Scientific Inc.
0.7316
+1.61%